混合物分析确定臭氧是儿童喘症状的驱动因素
Wenxin Lu1, Ellen A Eisen1, Liza Lutzker2
1Division of Environmental Health Sciences, School of Public Health, University of California Berkeley, Berkeley, Calif.
The journal of allergy and clinical immunology. Global
|July 21, 2025
概括
臭氧暴露与患有喘的儿童咳风险增加有关. 混合物分析确定了氧化,元素碳和臭氧是导致儿童喘症状 (如咳和喘息) 的关键因素.
科学领域:
- 环境健康 环境健康
- 儿科呼吸系统医学 儿科呼吸系统医学
- 流行病学 流行病学
背景情况:
- 环境空气污染物往往是相关的,这使得评估单个污染物对儿童喘的影响变得复杂.
- 以前的研究表明,各种空气污染物与儿童喘症状增加之间存在关联.
- 单一污染物模型在区分因果关系和因污染物相关性而导致的混方面存在局限性.
研究的目的:
- 调查空气污染物混合物对儿童喘症状的影响.
- 确定特定的空气污染物作为儿童喘恶化的关键风险因素.
- 解决单一污染物模型在理解复杂空气污染暴露中的局限性.
主要方法:
- 在加利福尼亚州弗雷斯诺招募了299名儿童 (63名患有喘). (儿童健康和空气污染研究).
- 评估了对8种环境空气污染物 (PM2.5,PM10,NOx,NO2,O3,CO,EC,PAHs) 的12个月暴露情况.
- 使用混合方法的重复测量分析,包括主要成分分析和基于量子的g计算 (q-gcomp).
主要成果:
- 在评估的8种空气污染物中观察到强烈的相互关联.
- 单一污染物模型显示臭氧暴露与更高的咳风险相关 (OR,1.39;95% CI,1.06-1.82).
- 混合物分析 (PCA,q-gcomp) 显示了氧化,元素碳和臭氧对咳和喘息的显著贡献.
结论:
- 臭氧已成为与儿童呼吸系统不良结果相关的重要空气污染物.
- 这项研究表明,臭氧可能是导致喘儿童持续咳的重要危险因素.
- 先进的混合物分析方法证实了臭氧的作用,即使考虑到其他污染物.
相关概念视频
01:29Asthma-I: Introduction
2.8K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.8K
01:26Asthma-II: Pathophysiology and Classification
2.9K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.9K
01:30Asthma-IV: Diagnostic and Management
2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
01:20Asthma: Pathogenesis and Management
599
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
599
01:24Asthma-III: Symptoms and Complications
2.6K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.6K
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
469
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
469